Describe common EGFR gene mutations in NSCLC as well as current guidelines for the identification of these alterations Evaluate the safety/efficacy data and sequencing strategies of available and emerging EGFR-targeted therapies Implement strategies to mitigate, manage, and anticipate adverse events associated with EGFR-targeted therapies in order to improve patient outcomes and minimize NSCLC treatment interruption
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/24-gdulc-101-1
- Start Date: 2024-05-29 05:00:00
- End Date: 2024-05-29 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Janssen (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest